Document is current
Any future updates will be listed below
-
Authors
Tummino, Tia A. https://orcid.org/0000-0001-9155-820X
Iliopoulos-Tsoutsouvas, Christos
Braz, Joao M. https://orcid.org/0000-0002-5792-1017
O’Brien, Evan S. https://orcid.org/0000-0002-2260-7722
Stein, Reed M.
Craik, Veronica https://orcid.org/0000-0001-5463-1199
Tran, Ngan K.
Ganapathy, Suthakar
Liu, Fangyu
Shiimura, Yuki https://orcid.org/0000-0002-9752-7399
Tong, Fei https://orcid.org/0000-0003-2880-8135
Ho, Thanh C.
Radchenko, Dmytro S. https://orcid.org/0000-0001-5444-7754
Moroz, Yurii S. https://orcid.org/0000-0001-6073-002X
Rosado, Sian Rodriguez
Bhardwaj, Karnika
Benitez, Jorge
Liu, Yongfeng https://orcid.org/0000-0002-8649-7892
Kandasamy, Herthana
Normand, Claire
Semache, Meriem
Sabbagh, Laurent https://orcid.org/0000-0002-5097-4298
Glenn, Isabella https://orcid.org/0009-0002-6443-1873
Irwin, John J. https://orcid.org/0000-0002-1195-6417
Kumar, Kaavya Krishna https://orcid.org/0000-0003-2283-4033
Makriyannis, Alexandros https://orcid.org/0000-0003-3272-3687
Basbaum, Allan I. https://orcid.org/0000-0002-1710-6333
Shoichet, Brian K. https://orcid.org/0000-0002-6098-7367
-
Funding
Funding for this research was provided by:
United States Department of Defense | Defense Advanced Research Projects Agency (HR0011-19-2-0020)
- License Information
-
More Information
Article History
Received: 1 June 2024
Accepted: 7 February 2025
First Online: 6 March 2025
Competing interests
: B.K.S. is co-founder of BlueDolphin, LLC, Epiodyne, and Deep Apple Therapeutics, Inc., and serves on the SRB of Genentech, the SABs of Schrodinger LLC and of Vilya Therapeutics. J.J.I. is a co-founder of BlueDolphin LLC and of Deep Apple Therapeutics. Y.S.M. is a VP of Sales and Marketing at Enamine Ltd. and a scientific advisor at Chemspace LLC. D.S.R. is an employee of Enamine, Ltd. H.K., C.N., M.S., and L.S. are employees of Domain Therapeutics North America Inc. The authors declare no other competing interests.
